扬子江药业以22.54亿元拿下北京世贸大厦，将在北京打造“大健康综合服务和体验中心”

Core Insights - Yangtze River Pharmaceutical Group's subsidiary, Beijing Yangtze River Real Estate Co., acquired the Shimao Building in Beijing for 2.254 billion yuan, approximately 30% lower than its assessed value of 3.22 billion yuan in August 2024, translating to a unit price of 32,000 yuan per square meter [1][1][1] Group 1: Acquisition Details - The Shimao Building has a total construction area of 70,200 square meters, comprising 4 underground floors and 24 above-ground floors, with approximately 60,000 square meters of above-ground space [1][1] - The remaining land use period for the property is less than 28 years, expiring on August 9, 2053 [1] Group 2: Strategic Expansion - Yangtze River Pharmaceutical Group has been actively registering subsidiaries and acquiring real estate in key regions such as the Greater Bay Area and Beijing-Tianjin-Hebei [1][1] - The company aims to transform into a full lifecycle health management service provider, establishing a multi-brand matrix to offer high-quality products and health management services [1][1] Group 3: Project Development - The company has initiated the construction of "Health Management Centers" in Taizhou, Jiangsu, and Hanzhong, Shaanxi, and has launched projects like life science industrial parks and health industry bases in Shanghai and Suzhou [1][1] - Over 90 health products have been introduced, demonstrating the company's commitment to deepening its presence in the health industry [1][1] Group 4: Future Plans - The company plans to establish a comprehensive health service and experience center in Beijing, which will serve as a key platform for showcasing health products and services to the public, partners, and media [1][1]